IDH1 and glioblastoma: Li et al. [13] showed the possibility of combining clinical parameters and radiomic features from dynamic О-(2-[18F]-fluoroethyl)-l-tyrosine PET in predicting the survival of patients with glioblastomas, IDH wild type, with moderate model quality.